TVGN
Tevogen Bio Holdings Inc
NASDAQ: TVGN · HEALTHCARE · BIOTECHNOLOGY
$6.64
+3.43% today
Updated 2026-04-30
Market cap
$27.03M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.08
Dividend yield
—
52W range
$4 – $76
Volume
0.2M
Tevogen Bio Holdings Inc (TVGN) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-37.5%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-15207.7%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.2%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-12.9%
2025-11-14
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-31 | $-7.96 | -430.7% | $4.29 | $4.48 | +4.4% |
| 2025-11-14 | $-1.50 | +50.0% | $0.44 | $0.39 | -12.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.50 | $-7.96 | -430.7% | — | — |
| 2025-09-30 | $-3.00 | $-1.50 | +50.0% | — | — |
| 2025-06-30 | $-2.50 | $-1.50 | +40.0% | — | — |
| 2025-03-31 | $-2.50 | $-3.50 | -40.0% | $396586.00 | — |
| 2024-12-31 | — | $-0.05 | — | — | — |
| 2024-09-30 | — | $-1.74 | — | — | — |
| 2024-06-30 | — | $-0.04 | — | — | — |
| 2024-03-31 | — | $-0.26 | — | — | — |
| 2023-12-31 | — | $-2.78 | — | — | — |
| 2023-09-30 | — | $-0.88 | — | — | — |
| 2023-06-30 | — | $-0.62 | — | — | — |
| 2023-03-31 | — | $0.05 | — | — | — |
Frequently asked questions
Has Tevogen Bio Holdings Inc beaten earnings estimates?
Tevogen Bio Holdings Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -37.5% over the last 4 quarters.
How does TVGN stock react to earnings?
TVGN stock has moved an average of -4.2% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.